close 73% of retail accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Home・Stock List・Mersana Therapeutics Inc
Search

Mersana Therapeutics Inc

Closed

SectorHealthcare

28.79 0.49

Neutral

Price update 31 Dec 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

28.16

Max

28.79

Key metrics

By Trading Economics

Income

17M

-7.5M

Sales

8M

11M

EPS

-1.51

Profit margin

-68.535

Employees

102

EBITDA

16M

-7.1M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+7.33% upside

Market Stats

By TradingEconomics

Market Cap

101M

144M

Previous open

28.3

Previous close

28.79

News Sentiment

By Acuity

34%

66%

88 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

0.311 / 0.355 Support & Resistance

Mersana Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

10 Jan 2025, 12:00 UTC

Major Market Movers

Mersana Shares Rise on Advances With Breast-Cancer Treatment

DJ

Read

Peer Comparison

Price change

Mersana Therapeutics Inc Forecast

Price Target

By TipRanks

7.33% upside

12 Months Forecast

Average 30.75 USD  7.33%

High 30.75 USD

Low 30.75 USD

Based on 4 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

0

Buy

4

Hold

0

Sell

Based on 4 analysts giving stock ratings to Mersana Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

0.311 / 0.355Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

88 / 374 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

96.14

↓-0.57%

A

Agilent Technologies Inc

136.19

↓-1%

VEEV

Veeva Systems Inc

223.11

↓-0.69%

HQY

HealthEquity Inc

91.51

↓-0.5%

PHR.US

Phreesia Inc

16.9

↓-0.59%
help-icon Live chat